Yuquan Zhang

Progress of Photodynamic and RNAi Combination Therapy in Cancer Treatment.

Yuanyu Huang, Yuhua Weng, Kun Li, 2021, ACS biomaterials science & engineering.

siRNA-functionalized lanthanide nanoparticle enables efficient endosomal escape and cancer treatment

B. Li, Xing-jie Liang, Yuanyu Huang, 2022, Nano Research.

Nintedanib alleviates pulmonary fibrosis in vitro and in vivo by inhibiting the FAK/ERK/S100A4 signalling pathway.

Honglan Zhu, Xiao Wu, Wenting Yang, 2022, International immunopharmacology.

Biosafety materials: Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system

Yuanyu Huang, Yuhua Weng, Huining He, 2022, Biosafety and Health.

Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice

Lin Pan, Wenting Yang, Menglin Zhang, 2023, Inflammation.

Amifostine attenuates bleomycin-induced pulmonary fibrosis in mice through inhibition of the PI3K/Akt/mTOR signaling pathway

Lin Pan, Wenting Yang, Juan Du, 2023, Scientific reports.

Chinese Expert Consensus on the Clinical Applications of Aminolevulinic Acid-Based Photodynamic Therapy in Female Lower Genital Tract Diseases (2022).

Lihui Wei, Youzhong Zhang, Huaijun Zhou, 2022, Photodiagnosis and photodynamic therapy.

A selective CB2R agonist (JWH133) protects against pulmonary fibrosis through inhibiting FAK/ERK/S100A4 signaling pathways

Yuquan Zhang, Chenkun Fu, Xiao Wu, 2023, BMC Pulmonary Medicine.